Win Coverage. Expand Access. Drive Adoption.

Market access doesn't end with ensuring coverage—and MMIT is with you every step of the way. MMIT helps pharmaceutical companies navigate the complexities of payer coverage, reimbursement, utilization management and patient access to drive stronger commercial outcomes. By combining industry-leading market access data, payer insights and pull-through solutions, we help brands secure favorable access, remove barriers to therapy, increase adoption and measure the impact of their market access investments.

Win Preferred Access with Priority Payers

Our core market access solutions help you secure preferred tier status where it matters. Leverage payer intelligence, coverage analytics and pull-through solutions to identify opportunities, strengthen value conversations and improve formulary positioning with high-priority health plans.

Speed Time to Coverage and Tier Parity

We help pharma companies reduce the time between regulatory approval and favorable coverage decisions. Gain early visibility into payer requirements, accelerate evidence generation and support market access strategies that drive faster formulary inclusion and tier parity.

Anticipate Competitive Coverage Shifts

Let us show you how to anticipate and respond to coverage shifts before erosion happens. Monitor competitive market access dynamics, track payer policy changes and uncover emerging threats to formulary positioning before they impact brand performance.

Validate and Defend Access Performance

Our solutions help ensure that negotiated wins are implemented and sustained. Validate contract execution, identify access gaps and monitor real-world behavior to protect coverage gains and maximize the value of market access investments.

Shorten Time to Therapy

Get patients on treatment faster with MMIT's key market access and promotional solutions. Identify access barriers, improve benefit verification workflows and equip providers with the information they need to accelerate treatment initiation and patient adherence.

Reduce Restrictive Policies

Our solutions help pharma companies overcome the many hurdles to patient access. Understand prior authorization requirements, step therapy restrictions and utilization management policies so you can develop more effective payer engagement and access strategies.

Close the Coverage-to-Utilization Gap

When access isn't converting into scripts, MMIT's solutions can help. Connect coverage, claims and prescribing data to identify barriers to utilization, uncover missed opportunities and improve the impact of pull-through initiatives.

Improve Field Targeting

We help pharma companies focus their efforts on the right accounts based on market access reality. Prioritize providers, health systems and payer-influenced accounts using coverage intelligence and access insights to maximize field effectiveness.

Increase Adoption in Favorable Environments

Leverage key MMIT solutions to change prescribing behavior and bolster growth. Identify high-opportunity accounts with favorable access conditions and activate targeted engagement strategies that drive utilization, prescribing and brand adoption.

Measure Pull-Through ROI

Our solutions not only improve your pull-through strategy but also measure its effectiveness. Quantify the impact of market access investments, evaluate program performance and connect access improvements to utilization, reimbursement and business outcomes.

Improve Claims Success and Reimbursement Accuracy

With our solutions, pharma companies can reduce denials, rework and payment delays. Equip providers and office staff with accurate coding, billing and reimbursement resources that improve claims success rates and support faster, more predictable payment.

Close Contract-to-Execution Gaps

Improve your pull-through operations with solutions designed to help ensure accurate coding, rebates and reimbursement. Validate that payer agreements are executed as intended, identify operational breakdowns and close gaps between negotiated access and real-world implementation.

Stay In Touch

Be the first to know about new arrivals and promotions

NEW RELEASE: The State of Patient Access 2026